Patients with BRCA mutations are offered breast MRI because of their increased risk of breast cancer, but no screening strategy is available for other BRCA-associated malignancies including pancreatic ductal adenocarcinoma. In this protocol, we optimize the use of several recent developments in body MRI for a rapid pancreatic screening in BRCA mutation carriers: first, rapid relatively motion insensitive T2-weighted imaging (T2WI) and navigator triggering (NT), where real-time tracking of the diaphragm position is performed. Secondly advances in diffusion-weighted-imaging (DWI). These techniques have changed our ability to screen for malignancies, in specific organs, such as the pancreas.
This abstract and the presentation materials are available to members only; a login is required.